Francesco Ancona, MD

Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair

12/01/2020

Ozan M. Demir , MBBS, MD, MRCP;

Marco B. Ancona , MD;

Andrea R. Munafo , MD;

Francesco Ancona , MD;

Stefano Stella , MD;

Eustachio Agricola , MD;

Alaide Chieffo , MD;

Antonio Colombo , MD;

Matteo Montorfano , MD;

Cosmo Godino , MD;

Antonio Sisinni , MD;

Approximately 50% of patients with severe mitral regurgitation referred for surgery have prohibitive surgical risk. MitraClip (Abbott Vascular) is an alternative therapy option in these patients. The aim of this study is to evaluate mid-term...

Approximately 50% of patients...

12/01/2020

Journal of Invasive Cardiology

Loss of Leaflet Insertion After Percutaneous Mitral Valve Repair Requiring Left Ventricular Assist Device Implantation: Usefulness of 3D Multiplanar Reconstruction

08/27/2019

Eustachio Agricola , MD;

Francesco Ancona , MD;

Francesco Calvo ;

Stefano Stella , MD;

Cristina Capogrosso , MD;

Roberto Spoladore , MD;

Paolo Denti , MD;

Francesco Melillo , MD;

Giulio Melisurgo , MD;

Alberto Margonato , MD;

Elisabetta Lapenna , MD;

Federico Pappalardo , MD;

Andrea Fisicaro , MD;

Alessandro Castiglioni , MD;

Recurrence of mitral regurgitation after MitraClip implantation is challenging. This case demonstrates that LVAD implantation may be a solution to address MitraClip failure.

Recurrence of mitral...

08/27/2019

Journal of Invasive Cardiology